These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 23389995)
1. Association of gray matter atrophy with age, β-amyloid, and cognition in aging. Oh H; Madison C; Villeneuve S; Markley C; Jagust WJ Cereb Cortex; 2014 Jun; 24(6):1609-18. PubMed ID: 23389995 [TBL] [Abstract][Full Text] [Related]
2. Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly. Oh H; Habeck C; Madison C; Jagust W Hum Brain Mapp; 2014 Jan; 35(1):297-308. PubMed ID: 22965806 [TBL] [Abstract][Full Text] [Related]
3. β-Amyloid affects frontal and posterior brain networks in normal aging. Oh H; Mormino EC; Madison C; Hayenga A; Smiljic A; Jagust WJ Neuroimage; 2011 Feb; 54(3):1887-95. PubMed ID: 20965254 [TBL] [Abstract][Full Text] [Related]
4. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469 [TBL] [Abstract][Full Text] [Related]
5. Effects of age and β-amyloid on cognitive changes in normal elderly people. Oh H; Madison C; Haight TJ; Markley C; Jagust WJ Neurobiol Aging; 2012 Dec; 33(12):2746-55. PubMed ID: 22429886 [TBL] [Abstract][Full Text] [Related]
6. Association of β-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy. Rabin JS; Pruzin J; Scott M; Yang HS; Hampton O; Hsieh S; Schultz AP; Buckley RF; Hedden T; Rentz D; Johnson KA; Sperling RA; Chhatwal JP Neurology; 2022 Jul; 99(3):e270-e280. PubMed ID: 35473760 [TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Bourgeat P; Chételat G; Villemagne VL; Fripp J; Raniga P; Pike K; Acosta O; Szoeke C; Ourselin S; Ames D; Ellis KA; Martins RN; Masters CL; Rowe CC; Salvado O; Neurology; 2010 Jan; 74(2):121-7. PubMed ID: 20065247 [TBL] [Abstract][Full Text] [Related]
8. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Drzezga A; Grimmer T; Henriksen G; Mühlau M; Perneczky R; Miederer I; Praus C; Sorg C; Wohlschläger A; Riemenschneider M; Wester HJ; Foerstl H; Schwaiger M; Kurz A Neurology; 2009 Apr; 72(17):1487-94. PubMed ID: 19339712 [TBL] [Abstract][Full Text] [Related]
9. Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease. Mecca AP; Barcelos NM; Wang S; Brück A; Nabulsi N; Planeta-Wilson B; Nadelmann J; Benincasa AL; Ropchan J; Huang Y; Gelernter J; Van Ness PH; Carson RE; van Dyck CH Neurobiol Aging; 2018 Jan; 61():207-214. PubMed ID: 29111487 [TBL] [Abstract][Full Text] [Related]
10. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype. Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173 [TBL] [Abstract][Full Text] [Related]
11. The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly. Wirth M; Oh H; Mormino EC; Markley C; Landau SM; Jagust WJ Alzheimers Dement; 2013 Nov; 9(6):687-698.e1. PubMed ID: 23474040 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Villemagne VL; Pike KE; Chételat G; Ellis KA; Mulligan RS; Bourgeat P; Ackermann U; Jones G; Szoeke C; Salvado O; Martins R; O'Keefe G; Mathis CA; Klunk WE; Ames D; Masters CL; Rowe CC Ann Neurol; 2011 Jan; 69(1):181-92. PubMed ID: 21280088 [TBL] [Abstract][Full Text] [Related]
13. The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction. Marchant NL; Reed BR; Sanossian N; Madison CM; Kriger S; Dhada R; Mack WJ; DeCarli C; Weiner MW; Mungas DM; Chui HC; Jagust WJ JAMA Neurol; 2013 Apr; 70(4):488-95. PubMed ID: 23400560 [TBL] [Abstract][Full Text] [Related]
14. In vivo mapping of amyloid toxicity in Alzheimer disease. Frisoni GB; Lorenzi M; Caroli A; Kemppainen N; Någren K; Rinne JO Neurology; 2009 Apr; 72(17):1504-11. PubMed ID: 19398705 [TBL] [Abstract][Full Text] [Related]
15. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects. Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Takahashi M; Nakagawara J; Iida H; Kishimoto T; Nagatsuka K Neuroimage Clin; 2017; 13():209-214. PubMed ID: 28003959 [TBL] [Abstract][Full Text] [Related]